Ignite Creation Date:
2024-05-06 @ 12:55 PM
Last Modification Date:
2024-10-26 @ 1:06 PM
Study NCT ID:
NCT03886831
Status:
COMPLETED
Last Update Posted:
2023-03-28
First Post:
2019-03-08
Brief Title:
A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies
Sponsor:
Prelude Therapeutics
Organization:
Prelude Therapeutics
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Refractory Chronic Myelomonocytic Leukemia |
| RelapsedRefractory Advanced Solid Tumors |
| RelapsedRefractory Diffuse Large B-cell Lymphoma |
| RelapsedRefractory Myelodysplasia |
| RelapsedRefractory Myelofibrosis |
| Adenoid Cystic Carcinoma |
| RelapsedRefractory Mantle Cell Lymphoma |
| RelapsedRefractory Acute Myeloid Leukemia |